These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term treatment of hypertension with methyldopa. VIII. Overview. Itskovitz HD J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668 [TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy. del Greco F; Huang CM; Quintanilla A J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673 [TBL] [Abstract][Full Text] [Related]
11. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia. Shoulson I Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445 [No Abstract] [Full Text] [Related]
12. Long-term treatment of hypertension with methyldopa. III. Tolerability. Caldwell JR; Metts JC J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of metoprolol and methyldopa in the treatment of hypertension. Karachalios GN Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553 [TBL] [Abstract][Full Text] [Related]
14. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension. Channick BJ; Kessler WB; Marks AD; Adlin EV Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035 [TBL] [Abstract][Full Text] [Related]
15. Parkinson's syndrome: aetiological factors and certain clinical features. Sutherland JM Aust N Z J Med; 1971 May; 1():Suppl 1:29-34. PubMed ID: 4949272 [No Abstract] [Full Text] [Related]
17. Drug-induced parkinsonism: a growing list. Martí Massó JF; Carrera N; Urtasun M Mov Disord; 1993; 8(1):125. PubMed ID: 8419801 [No Abstract] [Full Text] [Related]
18. [Exacerbation of parkinsonism caused by fluoxetine]. Gatto EM; Fernández Pardal M; Micheli F Medicina (B Aires); 1994; 54(2):182. PubMed ID: 7997141 [No Abstract] [Full Text] [Related]
19. [Treatment of drug-induced parkinsonism-like states with a drug used in the therapy of parkinsonism (methixene HCl)]. Münnich JE Med Welt; 1966 Oct; 40():2132-5. PubMed ID: 5920409 [No Abstract] [Full Text] [Related]